Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuromyelitis optica: clinical manifestations and neuroimaging features.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Alemtuzumab 3-year data show durable effect on MS disability
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Venocentric Lesions: An MRI Marker of MS?
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
The refinement of genetic predictors of multiple sclerosis.
Assessing upper limb function in multiple sclerosis.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Preventive healthcare use among males with multiple sclerosis.
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
Neurorehabilitation for other neurologic disorders.
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.

Pages